<DOC>
	<DOCNO>NCT00234936</DOCNO>
	<brief_summary>The purpose study evaluate ability adalimumab combine methotrexate improve quality life patient active RA .</brief_summary>
	<brief_title>Quality Life Study With Adalimumab Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Subject age 18 old good health ( Investigator discretion ) recent stable medical history Subject diagnosis rheumatoid arthritis define 1987 ACR criterion Subjects treatment failure criterion Mtx Mtx + another DMARD Subject consider investigator , reason , unsuitable candidate study Female subject pregnant breastfeeding consider become pregnant Previous treatment approve biological agent ( etanercept , infliximab , anakinra ) last 2 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>rheumatoid arthritis</keyword>
	<keyword>adalimumab</keyword>
	<keyword>quality life</keyword>
</DOC>